Evidence map›Paper›PMID 41440469›Full record

ArticleClinics and practice2025

Urinary Bladder Hamartoma: Narrative Literature Review of an Exotic Pathology and Rare Cause of LUTS.

Mohammed Rafea Kanaan, Meryem Akkoyun, Marcel Lafos, Markus Antonius Kuczyk, Hossein Tezval

Abstract readCase Reports
In one paragraph

Article in Clinics and practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mohammed Rafea KanaanDepartment of Urology and Urological Oncology, Hanover Medical School (MHH), 30625 Hanover, Germany.ORCID 0009-0001-1083-707X
Meryem AkkoyunDepartment of Urology and Urological Oncology, Hanover Medical School (MHH), 30625 Hanover, Germany.
Marcel LafosDepartment of Pathology, Hanover Medical School (MHH), 30625 Hanover, Germany.
Markus Antonius KuczykDepartment of Urology and Urological Oncology, Hanover Medical School (MHH), 30625 Hanover, Germany.
Hossein TezvalDepartment of Urology and Urological Oncology, Hanover Medical School (MHH), 30625 Hanover, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Urinary bladder hamartoma is an exceptionally rare benign lesion composed of disorganized yet mature tissue elements native to the bladder, including urothelium, fibrous stroma, smooth muscle, and occasionally adipose tissue. Unlike malignant tumors, it lacks cytological atypia, mitotic activity, or necrosis. Patients most often present with lower urinary tract symptoms (LUTS) or hematuria, though some cases are incidental findings. Associations with syndromic conditions such as Peutz-Jeghers, Beckwith-Wiedemann, Goldenhar, and Loeys-Dietz have been reported. Transurethral resection is the preferred treatment and has generally been curative. We report the first case in Germany-and the 16th worldwide-of urinary bladder hamartoma, occurring in a young adult male with bothersome LUTS. Because of its proximity to both ureteral orifices, only partial transurethral resection was performed, which provided durable symptom relief at 14 months of follow-up. This case highlights partial TUR as a pragmatic, organ-preserving alternative when complete resection is anatomically unsafe, while emphasizing that TURBT remains the standard of care. We provide a detailed discussion of the histopathological features, differential diagnosis, treatment considerations, and an updated narrative review of all reported cases.

Indexed as

benign tumorcase reporthamartomaLUTSurinary bladder

Identifiers

PMID41440469
PMCPMC12731898

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.